|

Impact of Protect Your Colon™ on CRC Screening

RECRUITINGN/ASponsored by Cedars-Sinai Medical Center
Actively Recruiting
PhaseN/A
SponsorCedars-Sinai Medical Center
Started2023-09-28
Est. completion2026-06-30
Eligibility
Age45 Years – 75 Years
Healthy vol.Accepted
Locations1 site

Summary

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.

Eligibility

Age: 45 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Individuals 45 to 75 years old
* No prior CRC screening or not up-to-date with CRC screening
* Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC)
* No prior colon polyps
* Additional inclusion criteria for participants recruited through Cint online survey panels: (i) appointment with a primary care provider up to 6 weeks from time of screening, and (ii) have Preferred Provider Organization (PPO) insurance.

Exclusion Criteria:

* Does not speak English
* Does not have internet access
* Any records flagged "break the glass" or "research opt out."

Conditions2

CancerColorectal Cancer Screening

Locations1 site

Cedars-Sinai Medical Center
Los Angeles, California, 90048
Antwon Chaplin, BA310.248.6790Antwon.Chaplin@cshs.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.